logo
Asian Market Value Stocks: 3 Companies Estimated Below Intrinsic Worth

Asian Market Value Stocks: 3 Companies Estimated Below Intrinsic Worth

Yahoo3 days ago
As global markets navigate a complex landscape of economic indicators and policy shifts, the Asian market has shown resilience, with indices in China and Japan posting gains amid strong corporate earnings and robust trade data. In this environment, identifying undervalued stocks can be crucial for investors seeking opportunities potentially mispriced by the market; these stocks may offer intrinsic value that is not yet reflected in their current trading prices.
Top 10 Undervalued Stocks Based On Cash Flows In Asia
Name
Current Price
Fair Value (Est)
Discount (Est)
SRE Holdings (TSE:2980)
¥3180.00
¥6212.44
48.8%
SILICON2 (KOSDAQ:A257720)
₩53700.00
₩105825.30
49.3%
Nanya Technology (TWSE:2408)
NT$43.95
NT$87.08
49.5%
Jiangsu Yunyi ElectricLtd (SZSE:300304)
CN¥11.08
CN¥22.02
49.7%
Heartland Group Holdings (NZSE:HGH)
NZ$0.80
NZ$1.58
49.5%
Guangdong Marubi Biotechnology (SHSE:603983)
CN¥40.73
CN¥79.39
48.7%
GEM (SZSE:002340)
CN¥6.54
CN¥13.00
49.7%
Finger (KOSDAQ:A163730)
₩13480.00
₩26287.68
48.7%
cottaLTD (TSE:3359)
¥442.00
¥867.58
49.1%
Andes Technology (TWSE:6533)
NT$276.50
NT$541.44
48.9%
Click here to see the full list of 277 stocks from our Undervalued Asian Stocks Based On Cash Flows screener.
Let's dive into some prime choices out of the screener.
SILICON2
Overview: SILICON2 Co., Ltd. is involved in the global distribution of cosmetics products and has a market cap of approximately ₩3.52 trillion.
Operations: The company generates revenue from its wholesale miscellaneous segment, amounting to ₩787.27 million.
Estimated Discount To Fair Value: 49.3%
SILICON2 is trading at ₩53,700, significantly below its estimated fair value of ₩105,825.3, presenting a potential undervaluation based on cash flows. Despite recent earnings volatility and high non-cash earnings, its revenue is expected to grow 20.6% annually—outpacing the Korean market's 7.2% growth rate—while profits are forecasted to increase by 20.75% per year. The company's strong first-quarter net income of KRW 38,785 million supports this outlook despite share price volatility.
Our comprehensive growth report raises the possibility that SILICON2 is poised for substantial financial growth.
Navigate through the intricacies of SILICON2 with our comprehensive financial health report here.
Damai Entertainment Holdings
Overview: Damai Entertainment Holdings Limited is an investment holding company engaged in content, technology, and IP merchandising and commercialization businesses in Hong Kong and the People's Republic of China, with a market cap of approximately HK$35.25 billion.
Operations: The company's revenue segments include CN¥2.06 billion from Damai, CN¥499.92 million from Drama Series Production, CN¥1.43 billion from IP Merchandising and Innovation Initiatives, and CN¥2.71 billion from its Film Technology and Investment, Production, Promotion and Distribution Platform.
Estimated Discount To Fair Value: 20.9%
Damai Entertainment Holdings, trading at HK$1.18, is undervalued with a fair value estimate of HK$1.49, based on cash flow analysis. Despite recent insider selling and share price volatility, the company reported CNY 6.70 billion in sales for the year ending March 2025—up from CNY 5.03 billion—and net income increased to CNY 363.58 million. Earnings are expected to grow significantly at over 40% annually, outpacing Hong Kong market forecasts.
Our earnings growth report unveils the potential for significant increases in Damai Entertainment Holdings' future results.
Get an in-depth perspective on Damai Entertainment Holdings' balance sheet by reading our health report here.
Accton Technology
Overview: Accton Technology Corporation engages in the research, development, manufacturing, and sale of network communication equipment across Taiwan, America, Asia, Europe, and internationally with a market cap of NT$552.76 billion.
Operations: Accton Technology Corporation generates revenue through its research, development, manufacturing, and sales activities in the field of network communication equipment across various regions including Taiwan, America, Asia, Europe, and other international markets.
Estimated Discount To Fair Value: 37.5%
Accton Technology, trading at NT$989, is undervalued with a fair value estimate of NT$1,581.54 based on cash flow analysis. Recent earnings showed significant growth with second-quarter revenue reaching TWD 60.60 billion and net income at TWD 5.03 billion. Despite high share price volatility, the company's earnings grew by 83.2% over the past year and are forecast to grow significantly at 22.8% annually, outpacing Taiwan's market expectations.
The analysis detailed in our Accton Technology growth report hints at robust future financial performance.
Take a closer look at Accton Technology's balance sheet health here in our report.
Key Takeaways
Click through to start exploring the rest of the 274 Undervalued Asian Stocks Based On Cash Flows now.
Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.
Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world.
Want To Explore Some Alternatives?
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include KOSDAQ:A257720 SEHK:1060 and TWSE:2345.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Singapore's Temasek prices $1.5 billion US dollar fixed and floating-rate bonds
Singapore's Temasek prices $1.5 billion US dollar fixed and floating-rate bonds

Yahoo

time24 minutes ago

  • Yahoo

Singapore's Temasek prices $1.5 billion US dollar fixed and floating-rate bonds

(Reuters) -Singapore's state investor Temasek said on Thursday its unit priced two U.S. dollar-denominated bonds totaling $1.5 billion, a day after launching the offer under its $25 billion medium-term note program. The unit, Temasek Financial (I), priced two $750 million two-year bonds, one with a 3.75% fixed rate and the other priced at a spread of 38 basis points over the Secured Overnight Financing Rate, the state investor said in a filing on the Singapore Exchange. The unit intends to use the net proceeds from the bond issuance to support Temasek and its investment holding companies in funding their ordinary course of business, the company said. Citi, Bank of America, Morgan Stanley and Societe Generale are the joint bookrunners. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Asia Stocks Seen Higher as Fed Cut Momentum Builds: Markets Wrap
Asia Stocks Seen Higher as Fed Cut Momentum Builds: Markets Wrap

Bloomberg

time26 minutes ago

  • Bloomberg

Asia Stocks Seen Higher as Fed Cut Momentum Builds: Markets Wrap

Asian stocks were poised for a mainly positive open Thursday as investors continued to ramp up bets that the Federal Reserve will cut interest rates next month. Equity-index futures pointed to gains in Australia and Hong Kong, while contracts for Japan declined. A gauge of US-listed Chinese shares rose for a second session, and the S&P 500 advanced as Apple Inc. and Inc. climbed. Treasury yields fell alongside the dollar.

Ligand Pharmaceuticals Among 3 Stocks Possibly Trading Below Intrinsic Value Estimates
Ligand Pharmaceuticals Among 3 Stocks Possibly Trading Below Intrinsic Value Estimates

Yahoo

time40 minutes ago

  • Yahoo

Ligand Pharmaceuticals Among 3 Stocks Possibly Trading Below Intrinsic Value Estimates

As the Nasdaq reaches record highs driven by surges in chip stocks and Apple, while the S&P 500 shows signs of losing momentum, investors are keenly observing market fluctuations influenced by tariff concerns and economic health. In such a climate, identifying stocks that may be trading below their intrinsic value can offer potential opportunities for those looking to invest wisely amidst these complex conditions. Top 10 Undervalued Stocks Based On Cash Flows In The United States Name Current Price Fair Value (Est) Discount (Est) StoneCo (STNE) $13.50 $26.82 49.7% Similarweb (SMWB) $7.56 $14.88 49.2% Old National Bancorp (ONB) $20.47 $40.10 49% MNTN (MNTN) $24.98 $49.17 49.2% Ligand Pharmaceuticals (LGND) $146.32 $290.34 49.6% Kyndryl Holdings (KD) $30.18 $59.38 49.2% Fiverr International (FVRR) $22.91 $45.03 49.1% BioLife Solutions (BLFS) $20.64 $40.11 48.5% Berkshire Hills Bancorp (BHLB) $24.04 $46.58 48.4% Atlantic Union Bankshares (AUB) $31.39 $62.54 49.8% Click here to see the full list of 167 stocks from our Undervalued US Stocks Based On Cash Flows screener. We're going to check out a few of the best picks from our screener tool. Ligand Pharmaceuticals Overview: Ligand Pharmaceuticals Incorporated is a biopharmaceutical company that develops and licenses biopharmaceutical assets globally, with a market cap of approximately $2.75 billion. Operations: Ligand Pharmaceuticals generates revenue through the development and licensing of biopharmaceutical assets on a global scale. Estimated Discount To Fair Value: 49.6% Ligand Pharmaceuticals appears undervalued, trading at US$146.32, significantly below its estimated fair value of US$290.34. Recent financial results show a turnaround with Q2 net income of US$4.85 million from a previous loss, and raised 2025 revenue guidance to US$200-225 million. The company has also secured new revenue streams through royalties and milestone payments from ZELSUVMI's launch, enhancing cash flow prospects despite slower overall revenue growth compared to the broader market expectations. According our earnings growth report, there's an indication that Ligand Pharmaceuticals might be ready to expand. Take a closer look at Ligand Pharmaceuticals' balance sheet health here in our report. Global-E Online Overview: Global-E Online Ltd. operates a direct-to-consumer cross-border e-commerce platform across Israel, the United Kingdom, the United States, and other international markets, with a market cap of approximately $5.91 billion. Operations: The company generates revenue of $796.77 million from its Internet Information Providers segment. Estimated Discount To Fair Value: 27.9% Global-E Online is trading at US$35.17, notably below its estimated fair value of US$48.75, highlighting potential undervaluation based on cash flows. Recent strategic partnerships with DHL and Shopify enhance its market position and revenue prospects, with earnings projected to grow 63.45% annually and expected profitability within three years. Despite a low forecasted return on equity of 16.6%, the company's revenue growth rate surpasses both industry and market averages, reinforcing its attractive valuation profile amidst robust expansion plans. The growth report we've compiled suggests that Global-E Online's future prospects could be on the up. Click to explore a detailed breakdown of our findings in Global-E Online's balance sheet health report. Warner Music Group Overview: Warner Music Group Corp. is a music entertainment company operating in the United States, the United Kingdom, Germany, and internationally with a market cap of approximately $15.66 billion. Operations: Warner Music Group generates revenue through its Recorded Music and Music Publishing segments, with the former focusing on recorded music sales, streaming, licensing, and artist services while the latter involves licensing compositions for use in recordings, public performances, and related rights. Estimated Discount To Fair Value: 10.3% Warner Music Group trades at US$31.15, slightly below its estimated fair value of US$34.73, indicating potential undervaluation based on cash flows. Despite recent earnings showing a net loss of US$16 million for Q3 2025, the company maintains a robust growth forecast with earnings expected to rise by 21.53% annually over the next three years. Strategic initiatives like the joint venture with Bain Capital for music catalog acquisitions may bolster long-term cash flow prospects amidst high debt levels. Upon reviewing our latest growth report, Warner Music Group's projected financial performance appears quite optimistic. Get an in-depth perspective on Warner Music Group's balance sheet by reading our health report here. Seize The Opportunity Navigate through the entire inventory of 167 Undervalued US Stocks Based On Cash Flows here. Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments. Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world. Contemplating Other Strategies? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include LGND GLBE and WMG. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store